Future Market Insights.png
Laryngoscopes Market is poised to grow at a CAGR of 5.4% by 2033, The rise in the use of laryngoscopes in airway management driving the laryngoscope industry growth Says Future Market Insights, Inc.
March 30, 2023 20:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, March 30, 2023 (GLOBE NEWSWIRE) -- The Laryngoscopes Market is expected to thrive at a CAGR of 5.4% between 2023 and 2033. The market is anticipated to cross a market...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Match Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MTCH
March 30, 2023 20:07 ET | The Rosen Law Firm PA
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Match Group, Inc. (NASDAQ: MTCH) between November 3, 2021 and...
Jamieson Wellness logo.jpg
Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders
March 30, 2023 20:05 ET | Jamieson Wellness Inc.
TORONTO, March 30, 2023 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that the Company has filed its management information circular...
OmniQ Print Logo Black.png
OMNIQ ANNOUNCES RECORD BREAKING ANNUAL REVENUE OF $102.5 MILLION, $25 MILLION FOR Q4 2022 AND REACHES POSITIVE CASH FLOW FROM OPERATIONS FOR FIRST TIME
March 30, 2023 20:04 ET | OMNIQ Corp.
SALT LAKE CITY, March 30, 2023 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Artificial Intelligence (AI) and IoT – based solutions announces record...
Omega-Logo-File-small.jpg
Omega Accounting Solutions Named #1 Best ERC Company for ERC Refunds
March 30, 2023 20:02 ET | Omega Accounting Solutions
IRVINE, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Omega Accounting Solutions, an accounting and data firm that empowers small businesses to make informed business decisions, today announced that it...
checkpoint.jpg
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
March 30, 2023 20:00 ET | Checkpoint Therapeutics, Inc
WALTHAM, Mass., March 30, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced...
LGL.jpg
Looking Glass Labs Completes Sale of GenZeroes Productions Inc. and GenX Smart Contract
March 30, 2023 20:00 ET | Looking Glass Labs Ltd
VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Looking Glass Labs Ltd. (“LGL” or the “Company”) (NEO: NFTX) (AQSE: NFTX) (OTC: LGSLF) (FRA: H1N), a leading Web3 platform...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer
March 30, 2023 20:00 ET | HUTCHMED (China) Limited
— NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China — — FRESCO-2 showed fruquintinib...
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Target Corporation: Please contact the Portnoy Law Firm to recover your losses; May 30, 2023 deadline
March 30, 2023 19:53 ET | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 30, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Target Corporation (NYSE: TGT)...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lumen Technologies, Inc. f/k/a CenturyLink, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LUMN, CTL
March 30, 2023 19:35 ET | The Rosen Law Firm PA
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Lumen Technologies, Inc. f/k/a CenturyLink, Inc. (NYSE:...
12...258564
Next Page keyboard_arrow_right